MAG and myeloid sarcoma: Additionally, antibodies toward MAG have been found in the CSF of MS patients, and MAG is thought to be a specific target of neuroinflammation, leading to its role in the dysregulation of axonal demyelination (Moller et al., 1989; Baig et al., 1991).